Publications

rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk.

Liu J, Lončar I, Collée JM, Bolla MK, Dennis J, Michailidou K, Wang Q, Andrulis IL, et al. Sci Rep. 2016 Nov 15;6:36874. doi: 10.1038/srep36874.

...


SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival. 

Jamshidi M, Fagerholm R, Khan S, Aittomäki K, Czene K, Darabi H, Li J, Andrulis IL, et al.  Oncotarget. 2015 Jul 22. [Epub ahead of print]

...


Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.

Brand JS, Hedayati E, Bhoo-Pathy N, Bergh J, Hall P, Humphreys K, Ludvigsson JF, Czene K.  Cancer. 2016 Oct 11. doi: 10.1002/cncr.30364. PMID: 27727

...


Time-dependent risk of depression, anxiety, and stress-related disorders in patients with invasive and in situ breast cancer.

Yang H, Brand JS, Fang F, Chiesa F, Johansson AL, Hall P, Czene K. Int J Cancer. 2017 Feb 15;140(4):841-852. doi: 10.1002/ijc.30514. Epub 2016 Nov 25.

...


TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.

Fagerholm R, Khan S, Schmidt MK, García-Closas M, Heikkilä P, Saarela J, Beesley J, Jamshidi M, et al. Oncotarget. 2017 Mar 14;8(11):18381-18398. do

...


Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients.

He W, Smedby KE, Fang F, Olsson H, Margolin S, Hall P, Czene K. J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx041.

...


Worse quality of life in young and recently-diagnosed breast cancer survivors compared to female survivors of other cancers: A cross-sectional study. 

Li J, Humphreys K, Eriksson M, Dar H, Brandberg Y, Hall P, Czene K.  Int J Cancer. 2016 Aug 3. doi: 10.1002/ijc.30370. PMID: 27486698

...